Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Self-Promoting Scientists: Building Trust with the Public

Posted on May 31st, 2017 by in Pharma R&D

 

Scientist

At Sequencing the Genome: Examining Modern Medicine, an event recently held in New York City and sponsored by The Atlantic, a series of panelists spoke on many aspects of genomics ranging from its progress in treating disease to its potential for stopping epidemics Continue reading “Self-Promoting Scientists: Building Trust with the Public” »

Assessing the State of the Genomic Revolution

Posted on May 29th, 2017 by in Pharma R&D

A few weeks ago, a number of experts in the field of genomics gathered in downtown Manhattan for Sequencing the Genome: Examining Modern Medicine, an event hosted by The Atlantic magazine. Continue reading “Assessing the State of the Genomic Revolution” »

Shouldn’t pharmacovigilance be less painful?

Posted on May 26th, 2017 by in Pharmacovigilance

PV white board

Even with advanced information technologies, too many companies and pharmacovigilance practitioners are still living with the pain of having to rely on ineffective and outdated systems and processes. Continue reading “Shouldn’t pharmacovigilance be less painful?” »

Compliant Monitoring of Adverse Events

Posted on May 24th, 2017 by in Pharmacovigilance

Developing and maintaining a solid strategy for screening for adverse events is critical for every pharmaceutical company. Without one, an adverse event could be reported in scientific literature without the company knowing — and failure to report it to the regulatory authorities could result in a serious warning. Continue reading “Compliant Monitoring of Adverse Events” »

  1. 1
  2. 2
  3. 3
  4. 4